Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.41% |
| 2 | Technology | 7.27% |
| 3 | Financials | 6.46% |
| 4 | Consumer Discretionary | 5.3% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
James Hardie Industries
JHX
$16.1B
| $202K | ﹤0.01% |
+16,879
| New | +$308K |
|
3352
Marvell Technology
MRVL
$174B
| $202K | ﹤0.01% |
8,906
-216,355
| -96% | -$5.19M |
|
|
CHNGU
3353
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
| $202K | ﹤0.01% |
+4,836
| New | +$256K |
|
3354
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
| $200K | ﹤0.01% |
762
-3,444
| -82% | -$1.17M |
|
3355
NCR Voyix
VYX
$1.19B
| $199K | ﹤0.01% |
18,336
-279,579
| -94% | -$4.8M |
|
3356
Meridian
MRBK
$236M
| $198K | ﹤0.01% |
+28,960
| New | +$267K |
|
3357
OraSure Technologies
OSUR
$286M
| $197K | ﹤0.01% |
+18,308
| New | +$131K |
|
3358
Children's Place
PLCE
$56.3M
| $196K | ﹤0.01% |
10,007
-209,733
| -95% | -$11.1M |
|
3359
Valhi
VHI
$380M
| $196K | ﹤0.01% |
15,867
+2,472
| +18% | +$42.9K |
|
3360
Waterstone Financial
WSBF
$375M
| $196K | ﹤0.01% |
13,447
-77,100
| -85% | -$1.31M |
|
|
AT
3361
DELISTED
Atlantic Power Corporation
AT
| $196K | ﹤0.01% |
91,525
+34,550
| +61% | +$78.6K |
|
|
FSD
3362
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
| $195K | ﹤0.01% |
+16,025
| New | +$234K |
|
3363
Intellicheck
IDN
$76.8M
| $192K | ﹤0.01% |
+56,741
| New | +$429K |
|
3364
ClearPoint Neuro
CLPT
$461M
| $191K | ﹤0.01% |
53,361
-18,112
| -25% | -$89K |
|
3365
Investar Holding Corp
ISTR
$415M
| $191K | ﹤0.01% |
14,987
-8,043
| -35% | -$163K |
|
3366
CALL
Synchrony
SYF
$25.3B
| $191K | ﹤0.01% |
+11,900
| New | +$347K |
|
|
ONCT
3367
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $191K | ﹤0.01% |
3,264
-144
| -4% | -$10.7K |
|
3368
Corbus Pharmaceuticals
CRBP
$165M
| $190K | ﹤0.01% |
+1,207
| New | +$204K |
|
3369
Boot Barn
BOOT
$4.8B
| $189K | ﹤0.01% |
14,589
+7,475
| +105% | +$238K |
|
|
ATCX
3370
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $189K | ﹤0.01% |
21,989
-585,625
| -96% | -$5.4M |
|
|
PBBI
3371
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
| $189K | ﹤0.01% |
+12,675
| New | +$190K |
|
3372
Biomerica
BMRA
$4.73M
| $187K | ﹤0.01% |
+3,277
| New | +$100K |
|
3373
Constellium
CSTM
$3.85B
| $187K | ﹤0.01% |
35,939
-304,113
| -89% | -$3.27M |
|
|
DX
3374
Dynex Capital
DX
$3.15B
| $186K | ﹤0.01% |
17,771
-370,415
| -95% | -$6.1M |
|
3375
Ecopetrol
EC
$34.1B
| $185K | ﹤0.01% |
19,495
-538,964
| -97% | -$8.92M |
|
Similar funds
Millennium Management's Q1 2020 Portfolio in Review
As of Q1 2020, Millennium Management held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Danaher worth $133M.
- Millennium Management's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Millennium Management added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Millennium Management's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Millennium Management fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Millennium Management opened 789 new positions and closed 1,154 in Q1 2020.
- Millennium Management's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.